Associate Professor Moo J. Cho, PhD, Cho is creating a delivery system to infect a cancer tumor with bacterial elements in order to encourage the body’s immune system to recognize and attack the tumor without the dangerous side effects commonly associated with chemotherapy and radiation treatments. He has received a five-year grant from the National Cancer Institute worth more than $1.5 million to support his work. READ MORE
Researchers at the UNC Eshelman School of Pharmacy have created a list of prescription drugs that increase the risk of falling for patients aged sixty-five and older who take four or more medications on a regular basis. READ MORE
The UNC Institute for Pharmacogenomics and Individualized Therapy has named Kevin Long as the director of its new pharmacoinformatics facility, which was created to develop resources for assessing drug-gene relationships, performing computational pharmacology analysis and providing IT platforms for pharmacogenomics studies. READ MORE